Pharmacist intervention may boost pneumococcal shots in hospital patients

NCT ID NCT04734925

Completed Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether a clinical pharmacist could help increase pneumococcal vaccination rates in patients at high risk for infection when they leave the hospital. Researchers tracked how many vaccine prescriptions were given to 167 at-risk adults. The goal was to see if the pharmacist's involvement helped doctors follow national vaccination recommendations.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this approach could help more at-risk patients get recommended pneumococcal vaccines before leaving the hospital.
What could go wrong: This is a small, completed study measuring only the number of vaccine protocols dispensed, not actual infection rates. Results may not apply to other settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VACCINATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pneumococcal infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VACCINATION

Contacts and locations

Show contact details

Locations

Chu Nimes

Nîmes, 30029, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.